FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Falk Nimmerjahn

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Anja Lux; Chris N Scanlan; Xiaojie Yu; Falk Nimmerjahn
Impact of immune complex size and glycosylation on IgG binding to human FcγRs.
Sidonia Mihai; Falk Nimmerjahn
The role of Fc receptors and complement in autoimmunity.
Inessa Schwab; Falk Nimmerjahn
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Falk Nimmerjahn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anja Lux; Chris N Scanlan; Xiaojie Yu; Falk Nimmerjahn
Impact of immune complex size and glycosylation on IgG binding to human FcγRs.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(8):4315-23.
2013: Sidonia Mihai; Falk Nimmerjahn
The role of Fc receptors and complement in autoimmunity.
Autoimmunity reviews 2013;12(6):657-60.
2013: Inessa Schwab; Falk Nimmerjahn
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Nature reviews. Immunology 2013;13(3):176-89.
2013: Anja Lux; Falk Nimmerjahn
Of mice and men: the need for humanized mouse models to study human IgG activity in vivo.
Journal of clinical immunology 2013;33 Suppl 1():S4-8.
2012: Inessa Schwab; Michaela Seeling; Susanne Aschermann; Markus Biburger; Lars Nitschke; Falk Nimmerjahn
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.
European journal of immunology 2012;42(12):3302-9.
2012: Christian M Karsten; Regina Kilchenstein; Gabriele Köhl; Markus Berger; Veroniqué Blanchard; Gordon D Brown; Marc Ehlers; Julia Figge; Fred D Finkelman; Nathaniel L Harris; Constanze Hess; Ralf Ludwig; Irina V Majoul; Jacqueline U McDonald; Falk Nimmerjahn; Selinda J Orr; Manoj K Pandey; Dominique Petzold; Delyth M Reid; Marcela Rosas; Richard T Strait; Philip R Taylor; Eva Wex; André Winkler; Detlef Zillikens; Jörg Köhl
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.
Nature medicine 2012;18(9):1401-6.
2012: Virginia Lopez-Parra; Beñat Mallavia; Falk Nimmerjahn; Ainhoa Oguiza; Guadalupe Ortiz-Muñoz; Carlota Recio; Julia Blanco; jesus egido; Oscar Lopez-Franco; Carmen Gomez-Guerrero
Fcγ receptor deficiency attenuates diabetic nephropathy.
Journal of the American Society of Nephrology : JASN 2012;23(9):1518-27.
2012: Michael Kasperkiewicz; Jörg Köhl; Tamás Laskay; Yask Gupta; Robert Häsler; Lars Hellberg; Misa Hirose; Hiroaki Iwata; Marcel F Jonkman; Kathrin Kalies; Steffen Möller; Falk Nimmerjahn; Ellen Rentz; Unni Samavedam; Enno Schmidt; Sabina Wende; Jürgen Westermann; Xinhua Yu; Detlef Zillikens; Ralf J Ludwig
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury.
The Journal of pathology 2012;228(1):8-19.
2012: Marietta Herrmann; Jörg Bornemann; Andrea Büscher; Siamon Gordon; Steffen Gräber; Alexander Heiss; Laura Helming; Martin Herrmann; Anne Kinkeldey; Falk Nimmerjahn; Cora Schäfer; Martin M N Schmitt; Willi Jahnen-Dechent
Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A.
Circulation research 2012;111(5):575-84.
2012: Brian Moldt; Falk Nimmerjahn; Paul W H I Parren; Pascal Poignard; Eva G Rakasz; Jörn E Schmitz; Niccole Schultz; Mami Shibata-Koyama; David Watkins; Anne-Sophie Dugast; D Cameron Dunlop; David T Evans; Samantha L Finstad; Donald N Forthal; Ann J Hessell; Shigeru Iida; Chenggang Jin; Yutaka Kanda; Gary Landucci; Michael D Alpert; Galit Alter; Dennis R Burton
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.
Journal of virology 2012;86(11):6189-96.
2012: Stefan Uderhardt; Reinhard E Voll; Susanne Aschermann; Wolfgang Bicker; Valery N Bochkov; Benjamin Frey; Martin Herrmann; Natacha Ipseiz; Falk Nimmerjahn; Olga V Oskolkova; Tobias Rothe; Kerstin Sarter; Georg Schett; Gerhard Krönke
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance.
Immunity 2012;36(5):834-46.
2012: Ulrike Harre; Per-Johan Jakobsson; Pierre Jurdic; Lars Klareskog; Grit Krumbholz; Elena Neumann; Falk Nimmerjahn; Elena Ossipova; Gabriella Sarmay; Hans-Ulrich Scherer; Roland Axmann; Holger Bang; Wolfgang Baum; Aline Bozec; Anca Irinel Catrina; Dan Georgess; Eszter Szarka; Rene Toes; Georg Schett
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
The Journal of clinical investigation 2012;122(5):1791-802.
2012: Sybille Böhm; Anja Lux; Inessa Schwab; Falk Nimmerjahn
The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.
Seminars in immunopathology 2012;34(3):443-53.
2012: Inessa Schwab; Georg Schett; Markus Biburger; Gerhard Krönke; Falk Nimmerjahn
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
European journal of immunology 2012;42(4):826-30.
2012: Markus Biburger; Falk Nimmerjahn
Low level of FcγRIII expression on murine natural killer cells.
Immunology letters 2012;143(1):53-9.
2012: Birgit Lehmann; Anja Lux; Markus Biburger; Sybille Böhm; Inessa Schwab; Falk Nimmerjahn
FcγRIIB: a modulator of cell activation and humoral tolerance.
Expert review of clinical immunology 2012;8(3):243-54.
2012: Gisela Ruiz-Heiland; Georg Schett; Michael Stock; Pawel Zerr; Wolfgang Baum; Jörg H Distler; Willy Hofstetter; Angelika Horn; Falk Nimmerjahn; Jochen Zwerina
Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis.
Annals of the rheumatic diseases 2012;71(3):400-7.
2012: Falk Nimmerjahn; Jeffrey V Ravetch
Translating basic mechanisms of IgG effector activity into next generation cancer therapies.
Cancer immunity 2012;12():13.
2011: Anne Baerenwaldt; Heike Danzer; Diana Dudziak; Gordon Heidkamp; Anja Lux; Bernd M Spriewald; Evelyn Ullrich; Falk Nimmerjahn
Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(46):18772-7.
2011: Marie-Laure Santiago-Raber; Nico van Rooijen; Montserrat Alvarez; Lucie Baudino; Falk Nimmerjahn; Shozo Izui
TLR7/9-mediated monocytosis and maturation of Gr-1(hi) inflammatory monocytes towards Gr-1(lo) resting monocytes implicated in murine lupus.
Journal of autoimmunity 2011;37(3):171-9.
2011: Falk Nimmerjahn; Jan D Lünemann
Expression and function of the inhibitory Fcγ-receptor in CIDP.
Journal of the peripheral nervous system : JPNS 2011;16 Suppl 1():41-4.
2011: Robert M Anthony; Falk Nimmerjahn
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo.
Current opinion in organ transplantation 2011;16(1):7-14.
2011: Anja Lux; Falk Nimmerjahn
Impact of differential glycosylation on IgG activity.
Advances in experimental medicine and biology 2011;780():113-24.
2011: Falk Nimmerjahn; Jeffrey V Ravetch
FcγRs in health and disease.
Current topics in microbiology and immunology 2011;350():105-25.
2010: Manuel Ritter; Olaf Gross; Sarah Kays; Jürgen Ruland; Falk Nimmerjahn; Shinobu Saijo; Jürg Tschopp; Laura E Layland; Clarissa Prazeres da Costa
Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(47):20459-64.
2010: Falk Nimmerjahn; Anja Lux; Heike Albert; Melissa Woigk; Christian Lehmann; Diana Dudziak; Patrick Smith; Jeffrey V Ravetch
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(45):19396-401.
2010: Gordon F Heidkamp; Kirsten Neubert; Eric Haertel; Falk Nimmerjahn; Michel C Nussenzweig; Diana Dudziak
Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells.
Immunology letters 2010;132(1-2):69-78.
2010: Mario M Zaiss; Kerstin Sarter; Andreas Hess; Klaus Engelke; Christina Böhm; Falk Nimmerjahn; Reinhard E Voll; Georg Schett; Jean-Pierre David
Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
Arthritis and rheumatism 2010;62(8):2328-38.
2010: Falk Nimmerjahn; Jeffrey V Ravetch
Antibody-mediated modulation of immune responses.
Immunological reviews 2010;236():265-75.
2010: Mario M Zaiss; Benjamin Frey; Andreas Hess; Jochen Zwerina; Julia Luther; Falk Nimmerjahn; Klaus Engelke; George Kollias; Thomas Hünig; Georg Schett; Jean-Pierre David
Regulatory T cells protect from local and systemic bone destruction in arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(12):7238-46.
2010: Manuel Comabella; Xavier Montalban; Kristina Kakalacheva; Deeqa Osman; Falk Nimmerjahn; Mar Tintoré; Jan D Lünemann
B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
Journal of neuroimmunology 2010;223(1-2):135-7.
2010: Imen Najjar; Pierre-Antoine Deglesne; Pierre-Olivier Schischmanoff; Emmanuelle E Fabre; Stéphanie Boisson-Dupuis; Falk Nimmerjahn; Georg W Bornkamm; Isabelle Dusanter-Fourt; Remi Fagard
STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient.
Journal of leukocyte biology 2010;87(6):1145-52.
2010: Anne Baerenwaldt; Markus Biburger; Falk Nimmerjahn
Mechanisms of action of intravenous immunoglobulins.
Expert review of clinical immunology 2010;6(3):425-34.
2010: Björn Tackenberg; Falk Nimmerjahn; Jan D Lünemann
Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.
Journal of clinical immunology 2010;30 Suppl 1():S65-9.
2010: S Aschermann; A Lux; A Baerenwaldt; Markus Biburger; Falk Nimmerjahn
The other side of immunoglobulin G: suppressor of inflammation.
Clinical and experimental immunology 2010;160(2):161-7.
2010: Hanne Schoenen; Barbara Bodendorfer; Kelly Jane Hitchens; Silvia Manzanero; Kerstin Werninghaus; Falk Nimmerjahn; Else Marie Agger; Steffen Stenger; Peter Andersen; Jürgen Ruland; Gordon D Brown; Christine Wells; Roland Lang
Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(6):2756-60.
2010: A Lux; S Aschermann; Markus Biburger; Falk Nimmerjahn
The pro and anti-inflammatory activities of immunoglobulin G.
Annals of the rheumatic diseases 2010;69 Suppl 1():i92-96.
2009: Shahzad N Syed; Stephanie Konrad; Kristina Wiege; Bernhard Nieswandt; Falk Nimmerjahn; Reinhold E Schmidt; J Engelbert Gessner
Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
European journal of immunology 2009;39(12):3343-56.
2009: Marie-Laure Santiago-Raber; Hirofumi Amano; Eri Amano; Lucie Baudino; Masako Otani; Qingshun Lin; Falk Nimmerjahn; Sjef Verbeek; Jeffrey V Ravetch; Yoshinari Takasaki; Sachiko Hirose; Shozo Izui
Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
Arthritis and rheumatism 2009;60(8):2408-17.
2009: Shunhua Guo; Anja S Mühlfeld; Tomasz A Wietecha; Carine J Peutz-Kootstra; Jolanta Kowalewska; Kenneth Yi; Min Spencer; Warangkana Pichaiwong; Falk Nimmerjahn; Kelly Hudkins; Charles E Alpers
Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis.
The American journal of pathology 2009;175(1):107-18.
2009: Björn Tackenberg; Ilijas Jelcic; Anne Baerenwaldt; Wolfgang H Oertel; Norbert Sommer; Falk Nimmerjahn; Jan D Lünemann
Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(12):4788-92.
2009: Lilyanne C Grevers; P L E M van Lent; Marije I Koenders; Birgitte Walgreen; Annet Sloetjes; Falk Nimmerjahn; J Sjef Verbeek; Wim B van den Berg
Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Arthritis and rheumatism 2009;60(2):396-407.
2009: Kerstin Werninghaus; Anna Babiak; Olaf Gross; Christoph Hölscher; Harald Dietrich; Else Marie Agger; Jörg Mages; Attila Mócsai; Hanne Schoenen; Katrin Finger; Falk Nimmerjahn; Gordon D Brown; Carsten J Kirschning; Antje Heit; Peter Andersen; Hermann Wagner; Jürgen Ruland; Roland Lang
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.
The Journal of experimental medicine 2009;206(1):89-97.
2008: Angela Giorgini; Heather J Brown; Helen R Lock; Falk Nimmerjahn; Jeffrey V Ravetch; Sjef Verbeek; Steven H Sacks; Michael G Robson
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(12):8745-52.
2008: Marielle A Otten; Gerben J van der Bij; Sjef Verbeek; Falk Nimmerjahn; Jeffrey V Ravetch; Robert H J Beelen; Jan G J van de Winkel; Marjolein van Egmond
Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):6829-36.
2008: Lucie Baudino; Yasuro Shinohara; Falk Nimmerjahn; Jun-ichi Furukawa; Munehiro Nakata; Eduardo Martínez-Soria; Franz Petry; Jeffrey V Ravetch; Shin-ichiro Nishimura; Shozo Izui
Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):6664-9.
2008: Heike Albert; Mattias Collin; Diana Dudziak; Jeffrey V Ravetch; Falk Nimmerjahn
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(39):15005-9.
2008: Lucie Baudino; Falk Nimmerjahn; Yasuro Shinohara; Jun-Ichi Furukawa; Franz Petry; Sjef Verbeek; Shin-Ichiro Nishimura; Jeffrey V Ravetch; Shozo Izui
Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(6):4107-12.
2008: Alexander Riedel; Falk Nimmerjahn; Stefan Burdach; Uta Behrends; Georg W Bornkamm; Josef Mautner
Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export.
European journal of immunology 2008;38(8):2090-5.
2008: Amanda Prislovsky; Bindumadhav Marathe; Amira Hosni; Alyssa L Bolen; Falk Nimmerjahn; Carl W Jackson; Darryl Weiman; Ted S Strom
Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.
Experimental hematology 2008;36(5):609-23.
2008: Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
Science (New York, N.Y.) 2008;320(5874):373-6.
2008: Lucie Baudino; Falk Nimmerjahn; Samareh Azeredo da Silveira; Eduardo Martinez-Soria; Takashi Saito; Michael Carroll; Jeffrey V Ravetch; Sjef Verbeek; Shozo Izui
Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(3):1948-53.
2008: Falk Nimmerjahn; Jeffrey V Ravetch
Anti-inflammatory actions of intravenous immunoglobulin.
Annual review of immunology 2008;26():513-33.
2008: Falk Nimmerjahn; Jeffrey V Ravetch
Analyzing antibody-Fc-receptor interactions.
Methods in molecular biology (Clifton, N.J.) 2008;415():151-62.
2008: Maria Allhorn; Anders I Olin; Falk Nimmerjahn; Mattias Collin
Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis.
PloS one 2008;3(1):e1413.
2008: Falk Nimmerjahn; Jeffrey V Ravetch
Fcgamma receptors as regulators of immune responses.
Nature reviews. Immunology 2008;8(1):34-47.
2007: Kutty Selva Nandakumar; Mattias Collin; Arne Olsén; Falk Nimmerjahn; Anna M Blom; Jeffrey V Ravetch; Rikard Holmdahl
Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis.
European journal of immunology 2007;37(10):2973-82.
2007: Falk Nimmerjahn; Robert M Anthony; Jeffrey V Ravetch
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(20):8433-7.
2007: Falk Nimmerjahn; Jeffrey V Ravetch
Antibodies, Fc receptors and cancer.
Current opinion in immunology 2007;19(2):239-45.
2007: Falk Nimmerjahn; Jeffrey V Ravetch
The antiinflammatory activity of IgG: the intravenous IgG paradox.
The Journal of experimental medicine 2007;204(1):11-5.
2007: Falk Nimmerjahn; Jeffrey V Ravetch
Fc-receptors as regulators of immunity.
Advances in immunology 2007;96():179-204.
2006: Falk Nimmerjahn
Activating and inhibitory FcgammaRs in autoimmune disorders.
Springer seminars in immunopathology 2006;28(4):305-19.
2006: Robert M Clancy; Petra Neufing; Ping Zheng; Marguerita O'Mahony; Falk Nimmerjahn; Tom P Gordon; Jill P Buyon
Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.
The Journal of clinical investigation 2006;116(9):2413-22.
2006: Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
Science (New York, N.Y.) 2006;313(5787):670-3.
2006: Yasuhito Hamaguchi; Yan Xiu; Kazuhiro Komura; Falk Nimmerjahn; Thomas F Tedder
Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
The Journal of experimental medicine 2006;203(3):743-53.
2006: Yoshikatsu Kaneko; Falk Nimmerjahn; Michael P. Madaio; Jeffrey V Ravetch
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors.
The Journal of experimental medicine 2006;203(3):789-97.
2006: Falk Nimmerjahn; Jeffrey V Ravetch
Fcgamma receptors: old friends and new family members.
Immunity 2006;24(1):19-28.
2006: E Hellebrand; Josef Mautner; Gilbert Reisbach; Falk Nimmerjahn; M Hallek; R Mocikat; Wolfgang Hammerschmidt
Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
Gene therapy 2006;13(2):150-62.
2005: Falk Nimmerjahn; Jeffrey V Ravetch
Divergent immunoglobulin g subclass activity through selective Fc receptor binding.
Science (New York, N.Y.) 2005;310(5753):1510-2.
2005: Falk Nimmerjahn; Pierre Bruhns; Ken Horiuchi; Jeffrey V Ravetch
FcgammaRIV: a novel FcR with distinct IgG subclass specificity.
Immunity 2005;23(1):41-51.
2005: Diana Dudziak; Falk Nimmerjahn; Georg W Bornkamm; Gerhard Laux
Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6672-6.
2005: Georg W Bornkamm; Christian Berens; Conny Kuklik-Roos; Jean-Marie Bechet; Gerhard Laux; Jürgen Bachl; Martin Korndoerfer; Martin Schlee; Michael Hölzel; Anastassia Malamoussi; Rob D Chapman; Falk Nimmerjahn; Josef Mautner; Wolfgang Hillen; Hermann Bujard; Jean Feuillard
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.
Nucleic acids research 2005;33(16):e137.
2005: Hidehiro Fukuyama; Falk Nimmerjahn; Jeffrey V Ravetch
The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells.
Nature immunology 2005;6(1):99-106.
2004: Josef Mautner; Dagmar Pich; Falk Nimmerjahn; Slavoljub Milosevic; Dinesh Adhikary; Heike Christoph; Klaus Witter; Georg W Bornkamm; Wolfgang Hammerschmidt; Uta Behrends
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.
European journal of immunology 2004;34(9):2500-9.
2004: Falk Nimmerjahn; Diana Dudziak; Ulrike Dirmeier; Gerd Hobom; Alexander Riedel; Martin Schlee; Louis M Staudt; Andreas Rosenwald; Uta Behrends; Georg W Bornkamm; Josef Mautner
Active NF-kappaB signalling is a prerequisite for influenza virus infection.
The Journal of general virology 2004;85(Pt 8):2347-56.
2003: Falk Nimmerjahn; Dieter J Kobelt; Alexander Steinkasserer; Annette Menke; Gerd Hobom; Uta Behrends; Georg W Bornkamm; Josef Mautner
Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses.
European journal of immunology 2003;33(12):3331-41.
2003: Diana Dudziak; Arnd Kieser; Ulrike Dirmeier; Falk Nimmerjahn; Susanne Berchtold; Alexander Steinkasserer; Gabriele Marschall; Wolfgang Hammerschmidt; Gerhard Laux; Georg W Bornkamm
Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
Journal of virology 2003;77(15):8290-8.
2003: Falk Nimmerjahn; Slavoljub Milosevic; Uta Behrends; Elizabeth M Jaffee; Drew M Pardoll; Georg W Bornkamm; Josef Mautner
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.
European journal of immunology 2003;33(5):1250-9.